These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26150030)

  • 1. Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection.
    Virseda-Rodríguez AJ; Padilla-Fernández B; López-Parra M; Santos-Antunes MT; Valverde-Martínez LS; Nieto-González MJ; San Miguel-Izquierdo JF; Lorenzo-Gómez A; García-Cenador MB; Antúnez-Plaza P; Lorenzo-Gómez MF
    Arch Ital Urol Androl; 2015 Jul; 87(2):136-40. PubMed ID: 26150030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy.
    Aning J; Dunn J; Daugherty M; Mason R; Pocock R; Ridler B; Thompson J; McGrath JS
    BJU Int; 2012 Dec; 110(11 Pt B):E608-13. PubMed ID: 22823412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series.
    Prader R; De Broca B; Chevallier D; Amiel J; Durand M
    J Endourol; 2017 Dec; 31(12):1284-1288. PubMed ID: 29037064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and complications of transurethral resection of bladder tumors in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study.
    Konishi T; Washino S; Nakamura Y; Ohshima M; Saito K; Arai Y; Miyagawa T
    BMC Urol; 2017 Dec; 17(1):118. PubMed ID: 29233118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
    Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
    Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
    Taylor K; Filgate R; Guo DY; Macneil F
    BJU Int; 2011 Nov; 108 Suppl 2():45-50. PubMed ID: 22085127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
    Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
    J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
    Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
    Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.